Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence
Molecules · 29.09.2024 · 29 (19) · 4626
DOI: 10.3390/molecules29194626 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecules, online erschienen am 29.09.2024. Verfasst von Ahrum Son und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Scripps Research, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Artificial Intelligence, Protein Engineering. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT), Korea Basic Science Institute (National research Facilities and Equipment Center), by Institute of Information & communications Technology Planning & Evaluation (IITP).
Abstract (Originalsprache)
The field of computational protein engineering has been transformed by recent advancements in machine learning, artificial intelligence, and molecular modeling, enabling the design of proteins with unprecedented precision and functionality. Computational methods now play a crucial role in enhancing the stability, activity, and specificity of proteins for diverse applications in biotechnology and medicine. Techniques such as deep learning, reinforcement learning, and transfer learning have dramatically improved protein structure prediction, optimization of binding affinities, and enzyme design. These innovations have streamlined the process of protein engineering by allowing the rapid generation of targeted libraries, reducing experimental sampling, and enabling the rational design of proteins with tailored properties. Furthermore, the integration of computational approaches with high-throughput experimental techniques has facilitated the development of multifunctional proteins and novel therapeutics. However, challenges remain in bridging the gap between computational predictions and experimental validation and in addressing ethical concerns related to AI-driven protein design. This review provides a comprehensive overview of the current state and future directions of computational methods in protein engineering, emphasizing their transformative potential in creating next-generation biologics and advancing synthetic biology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Scripps Research, La Jolla, CA 92037, USA.
- Department of Bio-AI Convergence, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
- Department of Convergent Bioscience and Informatics, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
- Protein AI Design Institute, Chungnam National University, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
- SCICS, Prove beyond AI, 99 Daehak-ro, Yuseong-gu, Daejeon 34134, Republic of Korea.
ORCID-Profile: Ahrum Son, Jongham Park, Woojin Kim, Hyunsoo Kim
Förderung
- National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT)
- Korea Basic Science Institute (National research Facilities and Equipment Center)
- by Institute of Information & communications Technology Planning & Evaluation (IITP)
- National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT)
- Korea Basic Science Institute (National Research Facilities and Equipment Center) grant funded by the Korean government (MSIT)
- Institute of Information & Communications Technology Planning & Evaluation (IITP) grant funded by the Korean government (MSIT)
Zitieren
APA
Son, A., Park, J., Kim, W., Yoon, Y., Lee, S., Park, Y., & Kim, H. (2024). Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence. Molecules, 29(19), 4626. https://doi.org/10.3390/molecules29194626
Vancouver
Son A, Park J, Kim W, Yoon Y, Lee S, Park Y, et al. Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence. Molecules. 2024;29(19):4626. doi:10.3390/molecules29194626
BibTeX
@article{Son2024,
author = {Son, Ahrum and Park, Jongham and Kim, Woojin and Yoon, Yoonki and Lee, Sangwoon and Park, Yongho and Kim, Hyunsoo},
title = {Revolutionizing Molecular Design for Innovative Therapeutic Applications through Artificial Intelligence},
journal = {Molecules},
year = {2024},
volume = {29},
number = {19},
pages = {4626},
doi = {10.3390/molecules29194626}
}
EUVIMED